Gene: CCDC93
Official Full Name: CCC complex scaffolding subunit CCDC93provided by HGNC
Gene Summary: Involved in Golgi to plasma membrane transport and endocytic recycling. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21660 | CCDC93 Knockout cell line (HeLa) | Human | CCDC93 | 1:3~1:6 | Negative | Online Inquiry |
KO21661 | CCDC93 Knockout cell line (HCT 116) | Human | CCDC93 | 1:2~1:4 | Negative | Online Inquiry |
KO21662 | CCDC93 Knockout cell line (HEK293) | Human | CCDC93 | 1:3~1:6 | Negative | Online Inquiry |
KO21663 | CCDC93 Knockout cell line (A549) | Human | CCDC93 | 1:3~1:4 | Negative | Online Inquiry |
CCDC93 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to provide a functional analysis of the CCDC93 gene's role in cellular processes. This product enables researchers to generate models that facilitate the study of gene function, signaling pathways, and cellular behaviors associated with CCDC93. By leveraging CRISPR-Cas9 technology, these knockout cell lines effectively silence the expression of the CCDC93 gene, allowing for the assessment of phenotypic changes that result from its ablation.
The key mechanism behind these knockout cell lines lies in the precise editing of the genomic DNA, leading to a loss-of-function phenotype. This functionality is vital in the exploration of CCDC93-related biological processes, including its involvement in cellular development, protein interactions, and potential contributions to various diseases. In both research and clinical settings, these cell lines serve as indispensable tools for understanding the gene's role and its implications in disease mechanisms, drug responses, or therapeutic targeting.
One significant advantage of CCDC93 Gene Knockout Cell Lines is their ability to provide consistent and reproducible results, enhancing the reliability of experimental outcomes. Unlike traditional gene knockdown methods, which often only reduce gene expression, these knockout cell lines offer a complete functional loss of the gene, enabling more definitive conclusions to be drawn regarding CCDC93’s role in cellular activities. Additionally, they can be applied across various biological assays, including high-throughput drug screening and genomic studies.
The value of these knockout cell lines extends to researchers and clinicians aiming to uncover novel insights into gene function and disease mechanisms. Their availability supports advancements in personalized medicine and targeted therapy development, thereby reinforcing the importance of genetic research in patient care.
Our company prides itself on delivering high-quality biological products backed by robust research and development expertise. We are committed to empowering the scientific community with innovative tools like the CCDC93 Gene Knockout Cell Lines, facilitating groundbreaking discoveries in the field of genetics and beyond.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.